Coverage
Filings
Danish biosolutions company Novonesis on Thursday raised its full-year sales forecast after reporting strong growth for the first nine months of the year, citing a robust performance across its markets.
Novonesis on Wednesday laid out new long-term financial targets, aiming to accelerate sales growth and expand profit margins through 2030 as part of its new ‘GROW’ strategy.
Novonesis has successfully completed its acquisition of dsm-firmenich's share of the Feed Enzyme Alliance, the company announced.
| 23 Jan 2017 |
| Trading by management and of close relations to management | 20 Jan 2017 |
| Group financial statement for 2016 | 18 Jan 2017 |
| Financial calendar 2017 | 20 Dec 2016 |
| Major shareholder announcement | 30 Nov 2016 |